Literature DB >> 25857563

Directly observed treatment short course for tuberculosis. What happens to them in the long term?

Marina Rajan Joseph1, Roshan Anna Thomas2, Sanjeev Nair3, Shibu Balakrishnan4, S Jayasankar5.   

Abstract

BACKGROUND: Though Directly Observed Treatment Short course (DOTS) is found effective in many controlled trials, few studies have examined its effectiveness under programmatic conditions. DOTS based Revised National TB Control Programme (RNTCP) was initiated in Ernakulam district of Kerala state in June 2000. It now covers all of India. It now seems appropriate to do an evaluation of RNTCP at field level. AIM: This study aims to document impact of DOTS in providing productive life to tuberculosis patients and measure rate of clinical recurrence under program conditions.
METHODS: Retrospective cohort study using interview with structured, peer reviewed and validated questionnaire among cohort of new smear positive patients registered in RNTCP from January 2002 to December 2003 and declared cured/Treatment completed. We have contacted 1173 patients (62.2% of the cohort) for the study at their homes by devising a strategy to identify and trace patients from address given in TB registers.
RESULTS: Mean age of identified patients is 51.9 years. 82.4% were males. 79% patients report full supervision in the intensive period. After seven years 64.1% are healthy, work and earn; 29.8% report residual respiratory problems; 0.3% of symptomatic patients were diagnosed with smear positive pulmonary tuberculosis. Relapse calculated as worst case scenario for full target population (dead and migrated inclusive) is 9.27%. Age specific mortality is 4-6 times higher than in a comparable general population.
CONCLUSIONS: DOTS treatment under program conditions makes a measurable reduction in tuberculosis morbidity. Though high proportion of patients remains productive after DOTS, a significant proportion complains of residual respiratory symptoms. Age specific mortality of Post tuberculosis patients is high compared to general population. Close follow up irrespective of duration of symptoms may help to determine the causes of high residual morbidity and mortality rates.
Copyright © 2015 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DOTS outcome; Quality of RNTCP; Relapse after DOTS; Residual respiratory problem; Tuberculosis treatment

Mesh:

Substances:

Year:  2015        PMID: 25857563     DOI: 10.1016/j.ijtb.2015.02.005

Source DB:  PubMed          Journal:  Indian J Tuberc        ISSN: 0019-5707


  4 in total

1.  A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment.

Authors:  Malvika Verma; Karan Vishwanath; Feyisope Eweje; Niclas Roxhed; Tyler Grant; Macy Castaneda; Christoph Steiger; Hormoz Mazdiyasni; Taylor Bensel; Daniel Minahan; Vance Soares; John A F Salama; Aaron Lopes; Kaitlyn Hess; Cody Cleveland; Daniel J Fulop; Alison Hayward; Joy Collins; Siddartha M Tamang; Tiffany Hua; Chinonyelum Ikeanyi; Gal Zeidman; Elizabeth Mule; Sooraj Boominathan; Ellena Popova; Jonathan B Miller; Andrew M Bellinger; David Collins; Dalia Leibowitz; Shelly Batra; Sandeep Ahuja; Manju Bajiya; Sonali Batra; Rohit Sarin; Upasna Agarwal; Sunil D Khaparde; Neeraj K Gupta; Deepak Gupta; Anuj K Bhatnagar; Kamal K Chopra; Nandini Sharma; Ashwani Khanna; Jayeeta Chowdhury; Robert Stoner; Alexander H Slocum; Michael J Cima; Jennifer Furin; Robert Langer; Giovanni Traverso
Journal:  Sci Transl Med       Date:  2019-03-13       Impact factor: 17.956

Review 2.  Mycobacterium tuberculosis and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae.

Authors:  Andreea-Daniela Meca; Liliana Mititelu-Tarțău; Maria Bogdan; Lorena Anda Dijmarescu; Ana-Maria Pelin; Liliana Georgeta Foia
Journal:  J Pers Med       Date:  2022-04-02

3.  Tuberculosis Treatment Outcome in Patients with TB-HIV Coinfection in Kuala Lumpur, Malaysia.

Authors:  Diana Safraa Selimin; Aniza Ismail; Norfazilah Ahmad; Rohani Ismail; Nurul Farhana Mohd Azman; Amaleena Azman
Journal:  J Trop Med       Date:  2021-05-29

4.  Prospective 1-year follow-up study of all cured, new sputum smear positive tuberculosis patients under the Revised National Tuberculosis Control Program in Hyderabad, Telangana State, India.

Authors:  Neeta Mathur; Chakrapani Chatla; Saba Syed; Yogesh Patel; Snigdha Pattnaik; Dilip Mathai; Adepu Rajesham
Journal:  Lung India       Date:  2019 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.